article

1. Reflections on the Practice of Geriatric Cardiology After a Mid-Career Geriatrics Fellowship..  Journal of the American College of Cardiology.  83:1619-1622. 2024
2. Palliative Care Education in Cardiovascular Disease Fellowships: A National Survey of Program Directors..  Journal of cardiac failure.  2024
3. JACC.  JACC. Advances.  3. 2024
4. Role of Cognitive Frailty in Older Adults With Cardiovascular Disease..  Journal of the American Heart Association.  13:-. 2024
5. Life's Essential 8: Optimizing Health in Older Adults..  JACC. Advances.  2. 2023
6. Physician Assessment of Aortic Stenosis Severity, Quantitative Parameters, and Long-Term Outcomes: Results from the KP-VALVE Project..  American heart journal.  32-47. 2023
7. The Association of Intensive Blood Pressure Treatment and Non-Fatal Cardiovascular or Serious Adverse Events in Older Adults with Mortality: Mediation Analysis in SPRINT..  European journal of preventive cardiology.  30:996-1004. 2023
8. JACC: Advances.  JACC. Advances.  2. 2023
9. Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults: A Randomized Clinical Trial..  JAMA network open.  6:-. 2023
10. JACC: Advances.  JACC. Advances.  2. 2023
11. Sarcopenia and Cardiovascular Diseases..  Circulation.  147:1534-1553. 2023
12. Limited English Proficiency in Older Adults Referred to the Cardiovascular Team..  The American journal of medicine.  136:432-437. 2023
13. It is time to be heard and understood: Readmission probably is not the outcome that matters among people with dementia considering percutaneous coronary intervention..  Journal of the American Geriatrics Society.  71:1017-1020. 2023
14. Geriatric Cardiology: Coming of Age..  JACC. Advances.  1. 2022
15. Peri-procedural code status for transcatheter aortic valve replacement: Absence of program policies and standard practices..  Journal of the American Geriatrics Society.  70:3378-3389. 2022
16. Comparison of coronary revascularization strategies in older adults presenting with acute coronary syndromes..  Journal of the American Geriatrics Society.  70:2235-2245. 2022
17. Geriatric and Palliative Care Specialists as Valued Members of The Multi-Disciplinary Heart Team..  The American journal of medicine.  135:810-812. 2022
18. Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT..  European heart journal. Quality of care & clinical outcomes.  7:e1-e2. 2021
19. Polypharmacy in Heart Failure: Progress But Also Problem..  The American journal of medicine.  134:1071-1073. 2021
20. The association of multimorbidity to mortality in older adults after permanent pacemaker placement..  Pacing and clinical electrophysiology : PACE.  44:919-928. 2021
21. Retrospective analysis of a pilot pharmacist-led hospice deprescribing program initiative..  Journal of the American Geriatrics Society.  69:1370-1376. 2021
22. Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review..  Journal of the American College of Cardiology.  76:2650-2670. 2020
23. Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart Failure..  Journal of cardiac failure.  27:190-197. 2020
24. Team-Based Approach to Management of Hypertension Associated with Angiogenesis Inhibitors..  Journal of cardiovascular translational research.  13:463-477. 2020
25. Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial..  The American journal of medicine.  133:e369-e370. 2020
26. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults..  Journal of the American Geriatrics Society.  68:78-86. 2019
27. Deprescribing in Older Adults With Cardiovascular Disease..  Journal of the American College of Cardiology.  73:2584-2595. 2019
28. Temporal Changes in Health Care Utilization among Participants of a Medically Supervised Weight Management Program..  The Permanente journal.  2019
29. Individual and Joint Effects of Pulse Pressure and Blood Pressure Treatment Intensity on Serious Adverse Events in the SPRINT Trial..  The American journal of medicine.  131:1220-1227.e1. 2018
30. Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future..  Journal of the American College of Cardiology.  71:1921-1936. 2018
31. Real-World Effectiveness of a Medically Supervised Weight Management Program in a Large Integrated Health Care Delivery System: Five-Year Outcomes..  The Permanente journal.  17-082. 2018
32. Contextualizing Myocardial Infarction: Comorbidities and Priorities in Older Adults..  The American journal of medicine.  130:1144-1147. 2017
33. A pilot study to assess the utility of five established variables to standardize exercise treadmill test reporting..  International journal of cardiology.  271-276. 2017
34. Can We Improve Mortality Estimation in Women After Treadmill Testing by Using Sex-Specific Scores?.  JAMA cardiology.  2:22-24. 2017
35. Multimorbidity is strongly associated with long-term but not short-term mortality after cardiac valve replacement..  International journal of cardiology.  417-21. 2016
36. Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease..  The American journal of cardiology.  117:1596-1603. 2016
37. Association of Age to Mortality and Repeat Revascularization in End-Stage Renal Disease Patients: Implications for Clinicians and Future Health Policies..  The Permanente journal.  20:4-9. 2016
38. Effect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement..  The Permanente journal.  20:27-32. 2015
39. Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease..  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.  47:e193-8. 2015
40. Atrial fibrillation and cor triatriatum sinister: a case report..  The Permanente journal.  19:e105-6. 2015
41. The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease..  Clinical cardiology.  37:546-51. 2014
42. Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease..  The Permanente journal.  18:11-6. 2014
43. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial..  Journal of the American College of Cardiology.  61:702-11. 2013
44. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation..  Pharmacoepidemiology and drug safety.  21:276-80. 2012
45. Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial)..  The American journal of cardiology.  109:36-41. 2011
46. Predictive values of Framingham risk and coronary artery calcium scores in the detection of obstructive CAD in patients with normal SPECT..  Angiology.  63:275-81. 2011
47. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial..  Circulation.  124:695-703. 2011
48. Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus..  Atherosclerosis.  217:514-7. 2011
49. No change in B-type natriuretic peptide levels assessed in the late postoperative period in patients with severe mitral regurgitation after mitral valve surgery..  Interactive cardiovascular and thoracic surgery.  12:768-71. 2011
50. Thiazolidinediones: a 2010 perspective..  The Permanente journal.  14:64-72. 2010
51. Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial..  Preventive cardiology.  12:9-18. 2009
52. The role of B-type and other natriuretic peptides in health and disease..  The Permanente journal.  12:32-43. 2008
53. Images in cardiovascular medicine. Pseudoaneurysm and intracardiac fistula caused by an infected paclitaxel-eluting coronary stent..  Circulation.  116:e364-5. 2007
54. Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus..  Thrombosis and haemostasis.  88:739-44. 2002
55. Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain..  Diabetic medicine : a journal of the British Diabetic Association.  19:862-6. 2002
56. Spontaneous coronary arterial dissection causing acute myocardial infarction..  Journal of interventional cardiology.  7:421-5. 1994
57. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody..  Journal of the American College of Cardiology.  23:1031-7. 1994
58. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries..  Circulation research.  73:952-67. 1993
59. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries..  Circulation.  86:1302-9. 1992